SUMMARY Electroneurophysiological studies were performed in 15 patients with familial amyloid neuropathy (ages 29 to 67 years) and in 16 symptom-free members of affected families (ages 9 to 64 years). These studies included needle EMG, motor conduction velocities of deep peroneal and median nerves, sensory conduction velocities, sensory potentials, and nerve potentials of the sural and median nerves. Results support the view that familial amyloid neuropathy is a peripheral neuropathy with predominantly axonal damage, which affects first the distal segments of the sensory fibres and then the motor fibres. It is suggested that, in some respects, this condition is akin to the dying-back neuropathies. Results also show that it is possible to detect the disease before it becomes obvious clinically, and this has important implications for genetic counselling.
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Familial amyloid polyneuropathy is an autosomal dominant disease which affects various organs, mainly the peripheral nervous system. Clinically it is a chronic, slowly progressive polyneuropathy, symmetrical, distal, starting in the lower extremities, predominantly sensory, with trophic symptoms, generally associated with digestive complaints, sexual impotence, and ending inexorably in cachexia and death.
It was described for the first time in 1951 by Andrade who also established its relationship with the presence of amyloid in the peripheral nerves, as well as in the skin, muscles, and digestive system.
Nevertheless, the pathogenesis of the neuropathy has not yet been well established. Coimbra and Andrade (1971) expressed the opinion that the polyneuropathy is not directly related to the presence of amyloid. It is possible that the error of protein metabolism which is responsible for the deposition of amyloid is also the origin of the neuropathy. Biochemical and electroneurophysiological investigations of the pathogenesis of this disease are in progress to try to define the type of polyneuropathy and to establish its relationship with the amyloid substance.
It must be emphasised that this is a genetically determined, dominant disease which seems to be spreading in Portugal, and outside through emigration, at a rate which should be predictable and which it is important to try to reduce. Most of the patients with familial amyloid polyneuropathy have children before they develop impotence and frequently before they have the first symptoms.
Electromyography and motor conduction velocity studies have been performed in patients with familial amyloid polyneuropathy by Tome and Coelho (1965) and Canijo and Andrade (1969) in Portugal, and Andersson and Blom (1972) in Sweden, and nerve fibre conduction velocities in teased preparations by Dyck and Lambert (1969) .
We have carried out neurophysiological studies in patients and clinically normal members of affected families with two aims-to elucidate the physiopathology of the polyneuropathy, and to find a way of predicting which of the children and siblings of patients will be affected with a view to providing genetic counselling. We also studied 16 members of 10 affected families (siblings and children of patients) aged between 9 and 34 years. No neurological complaints nor symptoms were detected in these individuals with the exception of one who had sciatic pain.
We repeated the electroneurophysiological studies one year later in two members of affected families.
Electroneurophysiological studies were performed using a three-channel DISA machine type 14 A 30 with digital averager and input transformer which allowed a more accurate detection of sensory potentials.
The following studies were carried out: needle EMG of the tibialis anterior, extensor digitorum brevis, and abductor pollicis brevis; motor conduction velocities, distal conduction time, proximal and distal thresholds, shape and voltage of the motor response; sensory potentials and nerve potentials (distal and proximal segments) of the median and sural nerves, sensory conduction velocities, conduction times, and sensory thresholds.
Surface electrodes were used for nerve stimulation and bipolar needle electrodes for muscle response detection. Buchthal and Rosenfalck's (1966) technique was used for the sensory potentials with sensory potential averaging when necessary. To test our results for sensory potentials, previous studies were carried out in normal subjects (Sales Luis et al., 1977) , and the results compared with those described by Buchthal and Rosenfalck (1966) . There were no significant differences.
Results

PATIENTS
Electromyography (Table 1 In the median nerve sensory potentials in the distal segment finger 2-wrist) was absent in two cases (13.3%), normal in one (6.6%), and low voltage, spread (1.7-7.5 jtV) in 12 (80%), with maximum conduction velocities normal or slightly decreased.
In the proximal segment (wrist-arm) studies were performed in 11 patients: nine showed low voltage nerve potentials with slightly decreased conduction velocities and two had normal values.
MEMBERS OF AFFECTED FAMILIES
Results of EMG studies were normal in all cases.
Motor conduction studies showed low voltage (<5 mV) polyphasic muscle response to stimulation of the deep peroneal nerve in six cases (37.5%).
As shown in Table 4 in the distal segment of the sural nerve there were absent or low voltage spread potentials in eight cases (50%) with sensory conduction velocities between 30 and 40 m/s. In the proximal segment of the sural nerve there were low voltage potentials in two cases (12.5%) with slightly decreased conduction velocity. In the distal segment of the median nerve there were low voltage spread potentials with normal conduction velocities in seven cases (46.6%) ( Table 4) .
REPEAT STUDIES (Table 5) Electroneurophysiological studies were repeated one year later on two apparently normal members of affected families, and in both cases signs of the Andrade's (1951) hypothesis that the neuropathy may be the consequence of a metabolic error still needs to be proved.
From the electroneurophysiological point of view our data indicate that in the patient group the most constantly found alterations were: absence of sensory potentials in the distal segment of sural nerve; decrease of amplitude and polyphasy of the muscle response to stimulation of the deep peroneal nerve; low amplitude, spread potentials in the distal segment of the median nerve; absence of or very low voltage of the potentials in the proximal segment of the sural nerve; low voltage potentials in the proximal segment of the median nerve; and normal or slightly decreased motor and sensory maximum conduction velocities.
In 50% of the clinically normal members of affected families, low voltage, spread potentials were detected only in the distal segment of the sural nerve or in the median nerve distal segment. Repeat studies in two members of affected families after a year showed evidence of the disease.
Thus, our data suggest that familial amyloid polyneuropathy is predominantly axonal, starting in the very distal portions of the sensory fibres of the lower limbs, then involving the distal parts of the motor fibres, and slowly ascending to more proximal segments of the nerve fibres.
These findings suggest that familial amyloid polyneuropathy should be considered, as other kinds of familial neuropathy, an axonal or neuronal form of dysfunction, probably of metabolic origin, leading to "atrophy" and "death" of the endings of the nerve fibres, and that the disease could be included among the neuropathies of the dying-back type.
The evidence that the small size sensory and sympathetic fibres are involved first, although the motor and deep sensation fibres are also affected later is, on the other hand, against this interpretation. The concept of dying-back neuropathy is not yet satisfactorily explained in terms of its cellular mechanism, although a recent model has been achieved with experimental acrylamide neuropathy.
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Indeed, in these studies, the axoplasmic transport was not shown to be disturbed as would be expected. Thus, it is still possible to speculate about familial amyloid polyneuropathy as a dying-back type of neuropathy arising from a metabolic error which affects primarily the sensory and sympathetic neurones even if they are not those with the largest and longest axons.
The results of the sensory studies in apparently normal members of affected families-namely, those who showed a subclinical evolution of the disease process on repeat testing-are significant enough to justify the attempt to detect patients in the preclinical stage and to give them genetic counselling.
